Search Within

Eytan Moshe Stein

Formats
  1. Meeting Abstract (217)
  2. Journal Article (109)
  3. Review (18)
  4. Research Letter (14)
  5. Editorial (6)
  6. Book Section (3)
  7. Guidelines (2)
  8. Correspondence (1)
  9. Miscellaneous (1)
Groups
  1. Adult Leukemia (371)
  2. Center for Hematologic Malignancies (371)
  3. Department of Medicine (371)
  4. Hematologic Malignancies, Division of (371)
  5. Hematology-Oncology Fellows (111)
  6. GSK Faculty (92)

More Groups

People
  1. Martin Tallman (118)
  2. Ross Levine (75)
  3. Aaron Goldberg (43)
  4. Andriy Derkach (33)
  5. Jan Bewersdorf (33)
  6. Christopher Famulare (31)

More People

Years
  1. 2025 (20)
  2. 2024 (45)
  3. 2023 (49)
  4. 2022 (34)
  5. 2021 (31)
  6. 2020 (30)

More Years

Publications
  1. Blood (171)
  2. Journal of Clinical Oncology (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (18)
  4. Haematologica (16)
  5. Blood Advances (14)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (186)
  2. Elsevier Inc. (32)
  3. American Society of Clinical Oncology (28)
  4. Ferrata Storti Foundation (16)
  5. Nature Publishing Group (15)
  6. Taylor & Francis Group (12)

More Publishers

Results (371)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer Center
    Journal Article

    Willis, C.; Menon, J.; Unni, S.; Au, T.; Yoo, M.; Biskupiak, J.; Brixner, D.; Ndife, B.; Joseph, G.; Bonifacio, G.; more...
    Leukemia Research (2019)

    Fulltext@MSK | Save
  • Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis
    Journal Article

    Yoshimi, A.; Lin, K. T.; Wiseman, D. H.; Rahman, M. A.; Pastore, A.; Wang, B.; Lee, S. C. W.; Micol, J. B.; Zhang, X. J.; de Botton, S.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid leukemia (ND AML): Updated results from a phase 1 study
    Meeting Abstract

    Roboz, G. J.; Dinardo, C. D.; Stein, E. M.; de Botton, S.; Mims, A. S.; Prince, G. T.; Altman, J. K.; Arellano, M. L.; Erba, H. P.; Pollyea, D. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML)
    Meeting Abstract

    Dinardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Frankfurt, O.; Schuh, A. C.; Martinelli, G.; Patel, P. A.; Raffoux, E.; Tan, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ivosidenib (IVO; AG-120) in IDH1-mutant relapsed or refractory myelodysplastic syndrome: Updated results from a phase 1 study
    Meeting Abstract

    DiNardo, C. D.; Foran, J. M.; Watts, J. M.; Stein, E. M.; de Botton, S.; Fathi, A. T.; Prince, G. T.; Stein, A. S.; Stone, R. M.; Patel, P. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid lukemia (ND AML): Updated results from a phase 1 study
    Meeting Abstract

    DiNardo, C. D.; Roboz, G. J.; Stein, E. M.; de Botton, S.; Mims, A. S.; Prince, G. T.; Altman, J. K.; Arellano, M. L.; Donnellan, W.; Erba, H. P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML)
    Meeting Abstract

    DiNardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Frankfurt, O.; Schuh, A. C.; DoĢˆhner, H.; Martinelli, G.; Raffoux, E.; Tan, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Extramedullary hematopoiesis of the renal pelvis in a patient with myelofibrosis
    Journal Article

    Stanchina, M.; Rosenbaum, E.; Pronko, A. J.; Liu, Y.; Lewis, N.; Yabe, M.; Stein, E.; Taylor, J.
    Journal of Oncology Practice (2019)

    Fulltext@MSK | Save
  • CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Research Letter

    Stanchina, M.; Pastore, A.; Devlin, S.; Famulare, C.; Stein, E.; Taylor, J.
    Journal of Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
    Review

    Ball, B.; Stein, E. M.
    Haematologica (2019)

    Fulltext@MSK | Save